Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes
- PMID: 6250050
- DOI: 10.1038/286264a0
Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes
Abstract
Arachidonic acid is metabolised either by cyclooxygenases to produce prostaglandins and thromboxanes or by lipoxygenases to produce mono-, di- and trihydroxyeicosatetraenoic acids (HETEs). Polymorphonuclear leukocytes (PMNs) release HETEs, including mono- and dihydroxy fatty acids, when exposed to stimuli such as the calcium ionophore A23187 (refs 1, 2). The mono-HETEs are assumed to be of particular importance with respect to effects on leukocyte function because they have been shown to possess both chemotactic and chemokinetic activities towards PMNs and eosinophils. However, we have now shown that the chemokinetic and aggregating activities released from rat and human PMNs exposed to ionophore A23187 (ref. 5) are not due to the release of mono-HETEs but to that of 5, 12-di-HETE (leukotriene B). This compound is active over the concentration range 10 pg ml-1 to 5 ng ml-1.
Similar articles
-
The production and characterisation of products of the lipoxygenase enzyme system released by rat peritoneal macrophages.Prostaglandins. 1980 Dec;20(6):1007-19. doi: 10.1016/0090-6980(80)90055-6. Prostaglandins. 1980. PMID: 6259695
-
Lipoxygenase products and the polymorphonuclear leucocyte.Agents Actions. 1980 Dec;10(6):548-50. doi: 10.1007/BF02024162. Agents Actions. 1980. PMID: 6267913
-
Arachidonic acid, leukotriene B4, and neutrophil activation.Ann N Y Acad Sci. 1983;414:125-39. doi: 10.1111/j.1749-6632.1983.tb31679.x. Ann N Y Acad Sci. 1983. PMID: 6322649 Review. No abstract available.
-
Neutrophil aggregating and chemokinetic properties of a 5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid isolated from human leukocytes.Prostaglandins. 1982 May;23(5):631-41. doi: 10.1016/s0090-6980(82)80003-8. Prostaglandins. 1982. PMID: 6289379
-
Leukotrienes and lipoxygenase factors: mediators and modulators of the allergic reaction.Allergol Immunopathol (Madr). 1982 Sep-Oct;10(5):385-94. Allergol Immunopathol (Madr). 1982. PMID: 6187199 Review.
Cited by
-
Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets.Curr Allergy Asthma Rep. 2016 Jul;16(7):48. doi: 10.1007/s11882-016-0628-3. Curr Allergy Asthma Rep. 2016. PMID: 27333777 Free PMC article. Review.
-
A lipid mediator controls neutrophil recruitment in acute lung injury--should we really be surprised?Crit Care. 2012 Oct 25;16(5):161. doi: 10.1186/cc11519. Crit Care. 2012. PMID: 23102473 Free PMC article.
-
Redox processes are major regulators of leukotriene synthesis in neutrophils exposed to bacteria Salmonella typhimurium; the way to manipulate neutrophil swarming.Front Immunol. 2024 Feb 7;15:1295150. doi: 10.3389/fimmu.2024.1295150. eCollection 2024. Front Immunol. 2024. PMID: 38384456 Free PMC article.
-
Inhibitory effect of methyleugenol on IgE-mediated allergic inflammation in RBL-2H3 cells.Mediators Inflamm. 2015;2015:463530. doi: 10.1155/2015/463530. Epub 2015 Apr 16. Mediators Inflamm. 2015. PMID: 25960618 Free PMC article.
-
Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability.J Clin Invest. 1989 Nov;84(5):1609-19. doi: 10.1172/JCI114338. J Clin Invest. 1989. PMID: 2553777 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
